Substituted morpholine compounds for the treatment of central nervous system disorders

Details for Australian Patent Application No. 2005238296 (hide)

Owner Warner-Lambert Company LLC

Inventors Glase, Shelly Ann; Barta, Nancy Sue; Reichard, Gregory Adam; Simons, Lloyd Jerome; Gray, David Lawrence firman; Xu, Wenjian

Agent Shelston IP

Pub. Number AU-A-2005238296

PCT Pub. Number WO2005/105763

Priority 60/567,244 30.04.04 US

Filing date 19 April 2005

Wipo publication date 10 November 2005

International Classifications

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/5377 (2006.01)

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/105763 Priority application(s): WO2005/105763

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238298-Compositions and methods for enhancing NK cell activity

2005238292-Ortho substituted aryl or heteroaryl amide compounds